Skip to main content
Log in

HIV screening 3-monthly cost effective in young MSM

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2018 US dollars

  2. Centers for Disease Control and Prevention

Reference

  • Neilan AM, et al. Cost-effectiveness of frequent HIV screening among high-risk young men who have sex with men in the United States. Clinical Infectious Diseases : 30 Jul 2020. Available from: URL: http://doi.org/10.1093/cid/ciaa1061

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

HIV screening 3-monthly cost effective in young MSM. PharmacoEcon Outcomes News 860, 21 (2020). https://doi.org/10.1007/s40274-020-7067-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-7067-z

Navigation